Marsillach_2007_Clin.Exp.Pharmacol.Physiol_34_347

Reference

Title : Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia - Marsillach_2007_Clin.Exp.Pharmacol.Physiol_34_347
Author(s) : Marsillach J , Martinez-Vea A , Marcas L , Mackness B , Mackness MI , Ferre N , Joven J , Camps J
Ref : Clinical & Experimental Pharmacology & Physiology , 34 :347 , 2007
Abstract : Marsillach_2007_Clin.Exp.Pharmacol.Physiol_34_347
ESTHER : Marsillach_2007_Clin.Exp.Pharmacol.Physiol_34_347
PubMedSearch : Marsillach_2007_Clin.Exp.Pharmacol.Physiol_34_347
PubMedID: 17324148

Related information

Citations formats

Marsillach J, Martinez-Vea A, Marcas L, Mackness B, Mackness MI, Ferre N, Joven J, Camps J (2007)
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia
Clinical & Experimental Pharmacology & Physiology 34 :347

Marsillach J, Martinez-Vea A, Marcas L, Mackness B, Mackness MI, Ferre N, Joven J, Camps J (2007)
Clinical & Experimental Pharmacology & Physiology 34 :347